Here is a compliant, informational SEO version that can be adapted for a healthcare website:
# Pimavanserin 34 mg UK: Uses, Prescription Information, Safety and FAQs
**Meta Title:** Pimavanserin 34 mg UK – Uses, Prescription & Safety Information
**Meta Description:** Learn about pimavanserin 34 mg, its approved use for Parkinson’s disease psychosis, dosage information, safety considerations, and UK prescription requirements.
**Suggested SEO Keywords:**
pimavanserin 34 mg UK, pimavanserin information UK, pimavanserin prescription UK, pimavanserin Parkinson’s psychosis, pimavanserin 34 mg capsules, pimavanserin safety, pimavanserin dosage, pimavanserin side effects, pimavanserin London, pimavanserin Manchester, pimavanserin Birmingham, pimavanserin Glasgow, pimavanserin Edinburgh, pimavanserin Liverpool, pimavanserin Bristol, pimavanserin Leeds, pimavanserin Newcastle, pimavanserin Sheffield, pimavanserin Cardiff
## What Is Pimavanserin 34 mg?
Pimavanserin is a prescription medicine used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. The current US prescribing information identifies **34 mg once daily** as the recommended dose without titration. ([FDA Access Data][2])
Pimavanserin is associated with the brand **NUPLAZID**. The FDA has approved 34 mg pimavanserin capsules for Parkinson’s disease psychosis. ([FDA Access Data][2])
## Pimavanserin and Parkinson’s Disease Psychosis
Parkinson’s disease psychosis can involve hallucinations or delusions. Pimavanserin's approved indication is specifically for hallucinations and delusions associated with Parkinson’s disease psychosis. It should not be presented as a general treatment for every type of psychosis. ([FDA Access Data][2])
Clinical information in the FDA prescribing documentation reports a six-week randomized, placebo-controlled study evaluating pimavanserin 34 mg in patients with Parkinson’s disease psychosis. ([FDA Access Data][3])
## Pimavanserin 34 mg Prescription Information in the UK
UK medicines are subject to MHRA regulation, and the MHRA provides official product information, including Summaries of Product Characteristics (SPCs), Patient Information Leaflets (PILs), and assessment reports. ([GOV.UK][4])
The legal classification of a medicine determines how it can be supplied. UK prescription-only medicines can only be obtained with a valid prescription from an authorised healthcare professional and supplied through the appropriate pharmacy route. ([GOV.UK][1])
Patients in **London, Manchester, Birmingham, Glasgow, Edinburgh, Liverpool, Bristol, Leeds, Newcastle, Sheffield and Cardiff** should therefore discuss pimavanserin with an appropriately qualified healthcare professional rather than purchasing prescription medicines from unregulated online sellers.
## Pimavanserin 34 mg Dosage
The FDA prescribing information states that the recommended pimavanserin dose is **34 mg orally once daily without titration** for its approved Parkinson’s disease psychosis indication. ([FDA Access Data][2])
Individual treatment decisions should be made by a healthcare professional after considering the patient's diagnosis, other medicines, medical history and potential interactions.
## Pimavanserin Safety Information
Pimavanserin has important safety considerations. The prescribing information contains a boxed warning concerning increased mortality in elderly patients with dementia-related psychosis. The medicine is not approved for dementia-related psychosis unless the hallucinations and delusions are associated with Parkinson’s disease psychosis. ([FDA Access Data][2])
The prescribing information also warns about **QT-interval prolongation** and advises avoiding use with medicines that also prolong the QT interval and in patients with relevant risk factors. ([FDA Access Data][5])
Patients should provide their doctor or pharmacist with a complete list of prescription medicines, non-prescription medicines and supplements before starting treatment.
## Pimavanserin 34 mg: Frequently Asked Questions
### What is pimavanserin 34 mg used for?
Pimavanserin 34 mg is indicated for hallucinations and delusions associated with Parkinson’s disease psychosis. ([FDA Access Data][2])
### Is pimavanserin a prescription medicine?
Prescription status depends on the applicable jurisdiction and product authorisation. In the UK, prescription-only medicines require a valid prescription and appropriate pharmacy supply. ([GOV.UK][1])
### How is pimavanserin 34 mg taken?
The FDA prescribing information recommends 34 mg orally once daily for the approved Parkinson’s disease psychosis indication. A healthcare
